Literature DB >> 12441654

The efficacy of medical and surgical treatment of endometriosis-associated infertility and pelvic pain.

Jaques Donnez1, Jean Squifflet, Céline Pirard, Pascale Jadoul, Christine Wyns, Mireille Smets.   

Abstract

This article is a review of the efficacy of medical and surgical treatment of endometriosis-associated infertility and pelvic pain. Endometriosis is the cause of pelvic pain (dysmenorrhea, dyspareunia) and infertility in more than 35% of women of reproductive age. Complete resolution of endometriosis is not yet possible but therapy has essentially three main objectives: (1) to reduce pain; (2) to increase the possibility of pregnancy; (3) to delay recurrence for as long as possible. It could be concluded that a consensus will probably never be reached on minimal and mild endometriosis. Nevertheless, because the Canadian study reported a large number of cases, we strongly support the view that visible endometriosis must be removed at the time of surgery. In cases of moderate and severe endometriosis-associated infertility, the combined approach (operative laparoscopy with GnRH-a) must be considered as 'first-line' treatment. The mean pregnancy rate of 50% reported in the literature following surgery provides scientific proof that operative treatment should be undertaken first to give our patients the best chance of conceiving naturally. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12441654     DOI: 10.1159/000066288

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  Cancer-Associated Mutations in Endometriosis without Cancer.

Authors:  Michael S Anglesio; Nickolas Papadopoulos; Ayse Ayhan; Tayyebeh M Nazeran; Michaël Noë; Hugo M Horlings; Amy Lum; Siân Jones; Janine Senz; Tamer Seckin; Julie Ho; Ren-Chin Wu; Vivian Lac; Hiroshi Ogawa; Basile Tessier-Cloutier; Rami Alhassan; Amy Wang; Yuxuan Wang; Joshua D Cohen; Fontayne Wong; Adnan Hasanovic; Natasha Orr; Ming Zhang; Maria Popoli; Wyatt McMahon; Laura D Wood; Austin Mattox; Catherine Allaire; James Segars; Christina Williams; Cristian Tomasetti; Niki Boyd; Kenneth W Kinzler; C Blake Gilks; Luis Diaz; Tian-Li Wang; Bert Vogelstein; Paul J Yong; David G Huntsman; Ie-Ming Shih
Journal:  N Engl J Med       Date:  2017-05-11       Impact factor: 91.245

2.  The effect of moderate to severe endometriosis on expression of growth differentiation factor-9 mRNA in human granulosa cells under controlled ovarian hyperstimulation.

Authors:  Sachiko Kawabe; Yoshiki Yamashita; Natsuho Saito; Kana Kokunai; Atsushi Hayashi; Masami Hayashi; Yoshito Terai; Kazunori Miyazaki; Masahide Ohmichi
Journal:  Reprod Med Biol       Date:  2015-05-19

3.  Nuclear expression of VDR and AHR is mutually exclusive in glandular cells in endometriosis.

Authors:  Francesco De Pascali; Livio Casarini; Christina Kuhn; Manuela Simoni; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Histochem Cell Biol       Date:  2021-06-21       Impact factor: 4.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.